Singapore, Sept. 3 -- Nanyang Biologics (NYB) enters a strategic collaboration with NVIDIA, Hewlett Packard Enterprise (HPE), and Equinix to build "VECURA"-an artificial intelligence (AI)-powered drug discovery platform that combines advanced predictive models with a proprietary library of millions of natural compounds.

Through this initiative, NYB aims to accelerate the development of next-generation health solutions across pharmaceuticals, dietary supplements, functional foods, and personal care. Designed as an "AI-as-a-Service" platform, VECURA seeks to reduce the therapeutic drug discovery timeline from the traditional 10-12 years to just few hours.

The signing event marked the beginning of the collaboration with world renowned heav...